
浏览全部资源
扫码关注微信
首都医科大学附属北京潞河医院中医中心,北京 101149
首都医科大学附属北京潞河医院眼科,北京 101149
✉李敏,主任医师。E-mail:361189141@qq.com
收稿:2025-02-06,
网络首发:2026-01-06,
纸质出版:2026-03-12
移动端阅览
安艳辰, 吴胜卫, 于曼, 等. 揿针联合玻璃酸钠滴眼液治疗中重度干眼的临床疗效观察[J]. 中国针灸, 2026,46(3):361-366.
AN Yanchen, WU Shengwei, YU Man, et al. Thumbtack needling combined with sodium hyaluronate eye drops for moderate-to-severe dry eye[J]. Chinese Acupuncture & Moxibustion, 2026, 46(3): 361-366.
安艳辰, 吴胜卫, 于曼, 等. 揿针联合玻璃酸钠滴眼液治疗中重度干眼的临床疗效观察[J]. 中国针灸, 2026,46(3):361-366. DOI: 10.13703/j.0255-2930.20250206-0002.
AN Yanchen, WU Shengwei, YU Man, et al. Thumbtack needling combined with sodium hyaluronate eye drops for moderate-to-severe dry eye[J]. Chinese Acupuncture & Moxibustion, 2026, 46(3): 361-366. DOI: 10.13703/j.0255-2930.20250206-0002.
目的:
2
探讨揿针联合玻璃酸钠滴眼液治疗中重度干眼中的临床疗效。
方法:
2
将72例中重度干眼患者随机分为揿针治疗组和常规治疗组,每组36例。常规治疗组接受玻璃酸钠滴眼液治疗,揿针治疗组在常规治疗组的基础上予揿针治疗,取双侧睛明、承泣、球后。每周治疗2次,连续治疗4周。比较两组患者治疗前后中医证候评分、首次泪膜破裂时间(NIBUTf)、平均泪膜破裂时间(NIBUTav)、泪液分泌试验Ⅰ(SⅠT)、角膜荧光素钠染色(FL)评分、眼表疾病指数(OSDI)评分和不良反应发生率,并评定临床疗效。
结果:
2
治疗后,两组患者各项中医证候评分及总分、FL评分、OSDI评分均较治疗前降低(
P
<
0.05),且揿针治疗组低于常规治疗组 (
P
<
0.05);两组患者NIBUTf、NIBUTav、SⅠT均较治疗前升高(
P
<
0.05),且揿针治疗组高于常规治疗组(
P
<
0.05)。揿针治疗组不良反应发生率为5.6%(2/36),低于常规治疗组的11.1%(4/36,
P
<
0.05)。揿针治疗组的总有效率为97.2%(35/36),高于常规治疗组的83.3%(30/36,
P
<
0.05)。
结论:
2
揿针联合玻璃酸钠滴眼液可改善中重度干眼患者的泪膜稳定性、泪液分泌量及角膜上皮损伤程度,具有较好的临床疗效和较低的不良反应发生率。
Objective
2
To investigate the clinical efficacy of thumbtack needling combined with sodium hyaluronate eye drops in the treatment of moderate-to-severe dry eye.
Methods
2
A total of 72 patients with moderate-to-severe dry eye were randomly divided into a thumbtack needling group and a conventional treatment group
with 36 patients in each group. The conventional treatment group received sodium hyaluronate eye drops
while the thumbtack needling group received additional thumbtack needling based on the same conventional therapy. The selected points for thumbtack needling included bilateral Jingming (BL1)
Chengqi (ST1)
and Qiuhou (EX-HN7). Treatment was performed twice a week for four consecutive weeks. Traditional Chinese medicine (TCM) syndrome scores
first non-invasive tear break-up time (NIBUTf)
average non-invasive tear break-up time (NIBUTav)
Schirmer Ⅰ test (SⅠT)
corneal fluorescein sodium staining (FL) score
ocular surface disease index (OSDI) score before and after treatment
and adverse event incidence were compared between the two groups. Clinical efficacy was also evaluated.
Results
2
Compared before treatment
the TCM syndrome scores (individual and total)
FL scores
and OSDI scores were significantly lower in both groups after treatment (
P
<
0.05)
with the thumbtack needling group showing greater reductions than the conventional treatment group (
P
<
0.05). Compared before treatment
NIBUTf
NIBUTav
and SⅠT were significantly increased in both groups after treatment (
P
<
0.05)
with the thumbtack needling group showing greater improvements than the conventional treatment group (
P
<
0.05). The incidence of adverse reactions was 5.6% (2/36) in the thumbtack needling group
which was lower than 11.1% (4/36) in the conventional treatment group (
P
<
0.05). The total effective rate was 97.2% (35/36) in the thumbtack needling group
which was significantly higher than 83.3% (30/36) in the conventional treatment group (
P
<
0.05).
Conclusion
2
Thumbtack needling combined with sodium hyaluronate eye drops could effectively improve tear film stability
tear secretion volume
and corneal epithelial damage in patients with moderate-to-severe dry eye. This combined therapy demonstrates favorable clinical efficacy and a lower incidence of adverse reactions.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621